This site is intended for health professionals only
Thursday 29 September 2016 Instagram
Share |

Treatment policies for smear results questioned

Treatment policies for smear results questioned

Three studies published on bmj.com today examine the merits of conservative versus aggressive treatment policies of women with low-grade abnormal results detected by cervical screening.

Together they form the Trial of Management of Borderline and Other Low-grade Abnormal Smears (TOMBOLA).

The first finds no benefit in referring these women for colposcopy (a detailed inspection of the cervix to detect pre-cancerous cells) compared to regular surveillance.

A second paper also questions the benefit of immediate treatment to remove abnormal tissue from the cervix (a procedure known as large loop excision) over the more conservative strategy of taking small tissue samples (biopsies) and recalling women for treatment only if pre-cancerous lesions are confirmed.

Finally, a cost effectiveness study shows that immediate colposcopy is no more, or no less, cost effective than regular surveillance.

In the first study, women were randomised to either repeat smears or to immediate referral for colposcopy. All women were tracked for three years and underwent a colposcopic examination at the end of the study.

The results showed that, although colposcopy detects more high-grade pre-cancerous lesions (known as cervical intraepithelial neoplasia or CIN) than surveillance, it causes more side effects and can lead to over-treatment, complications and later problems in pregnancy.

In the second study, women were randomised to either immediate large loop excision or up to four biopsies with recall for treatment if necessary. Again, women were tracked for three years and underwent a colposcopic examination at the end of the study.

There was no difference between the policies with regard to detection of high-grade cervical intraepithelial neoplasia over three years. However, immediate large loop excision resulted in substantial over-treatment and more after effects than biopsy and recall.

A cost effectiveness study shows that, taking into account costs, outcomes, and quality of life, follow-up by immediate colposcopy is no more and no less cost effective than follow-up by regular surveillance. The authors conclude that "there is no compelling economic reason to favour any one follow-up method over either of the others."

BMJ

Ads by Google

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?